Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick W Sullivan

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 10, 2011
Are utilities bounded at 1.0? Implications for statistical analysis and scale developmentPatrick W Sullivan
BMJ (Clinical Research Ed.)|April 16, 2005
Switching prescription drugs to over the counter: consumers may benefit financially in examples from the USPatrick W Sullivan
Pharmacotherapy|September 28, 2005
Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patientsRobert MacLaren, Patrick W Sullivan
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 21, 2006
Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative samplePatrick W Sullivan, Vahram Ghushchyan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 5, 2005
Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patientsRobert MacLaren, Patrick W Sullivan
Expert Opinion on Pharmacotherapy|October 6, 2006
Economic evaluation of sustained sedation/analgesia in the intensive care unitRobert MacLaren, Patrick W Sullivan
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 21, 2006
Preference-Based EQ-5D index scores for chronic conditions in the United StatesPatrick W Sullivan, Vahram Ghushchyan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2016
EQ-5D Scores for Diabetes-Related ComorbiditiesPatrick W Sullivan, Vahram H Ghushchyan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 29, 2004
The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistaminesPatrick W Sullivan, Michael B Nichol
The Annals of Pharmacotherapy|January 27, 2004
Therapeutic and economic consequences of OTC loratadineKavita V Nair, Patrick W Sullivan
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 10, 2011
Are utilities bounded at 1.0? Implications for statistical analysis and scale developmentPatrick W Sullivan
BMJ (Clinical Research Ed.)|April 16, 2005
Switching prescription drugs to over the counter: consumers may benefit financially in examples from the USPatrick W Sullivan
Pharmacotherapy|September 28, 2005
Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patientsRobert MacLaren, Patrick W Sullivan
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 21, 2006
Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative samplePatrick W Sullivan, Vahram Ghushchyan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 5, 2005
Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patientsRobert MacLaren, Patrick W Sullivan
Expert Opinion on Pharmacotherapy|October 6, 2006
Economic evaluation of sustained sedation/analgesia in the intensive care unitRobert MacLaren, Patrick W Sullivan
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 21, 2006
Preference-Based EQ-5D index scores for chronic conditions in the United StatesPatrick W Sullivan, Vahram Ghushchyan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2016
EQ-5D Scores for Diabetes-Related ComorbiditiesPatrick W Sullivan, Vahram H Ghushchyan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 29, 2004
The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistaminesPatrick W Sullivan, Michael B Nichol
The Annals of Pharmacotherapy|January 27, 2004
Therapeutic and economic consequences of OTC loratadineKavita V Nair, Patrick W Sullivan
Pageof 7